Literature DB >> 8308999

Detection of interleukin-1 activity in human bladder cancer cell lines.

O Hayashi1, M Akashi, M Fujime, K Hanazawa, R Kitagawa.   

Abstract

Detection of interleukin (IL)-1 activity was studied in two human bladder cancer cell lines, T24 and EJ1, and one rat bladder carcinoma cell line, 804G. Significantly high proliferation of mouse thymocytes in the assay of IL-1 activity was observed in the conditioned medium (CM) of T24 cells, indicating that the cells released IL-1-like activity. Enzyme-linked immunosorbent assay (ELISA) and Northern blot analysis showed the presence of both IL-1 alpha and IL-1 beta in the CM of T24 cells and expression of mRNAs of both cytokines in the cells. Interleukin-1 activity in EJ1 cells, which produced a little activity, was induced by E. coli lipopolysaccharide (LPS) while it was not induced in T24 by either LPS or other test substances. Conditioned medium of T24 increased proliferation of both T24 and EJ1 in cell-growth assay. Further investigation of the mode of action and role of cytokines, especially those from tumor cells themselves, is necessary in relation to BCG or photodynamic therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8308999     DOI: 10.1016/s0022-5347(17)35080-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Enhancing the immunotherapeutic potential of mycobacteria by transfection with tumour necrosis factor-alpha.

Authors:  J L Haley; D G Young; A Alexandroff; K James; A M Jackson
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

2.  Involvement of hepatocyte growth factor in increased integrin expression on HepG2 cells triggered by adhesion to endothelial cells.

Authors:  N Kawakami-Kimura; T Narita; K Ohmori; T Yoneda; K Matsumoto; T Nakamura; R Kannagi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Low interleukin-1alpha messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma.

Authors:  M Seddighzadeh; G Steineck; O Jansson; P Larsson; H Wijkström; J Adolfsson; N Portwood; J Hansson; S Linder
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.